Loss of NR4A1 inhibits TGF-β-induced epithelial-to-mesenchymal transition (EMT), revealing a novel mechanism by which the microenvironment stimulates breast cancer cell invasion and metastasis (Zhou et al., 2014). The gene discussed is NR4A1; the disease is breast carcinoma.